Ventyx biosciences to participate in two upcoming investor conferences

Encinitas, calif., nov. 22, 2022 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx) (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced that company executives will provide a company overview during fireside chats at the following upcoming investor conferences:
VTYX Ratings Summary
VTYX Quant Ranking